The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Oncology Precision Medicine Market Research Report 2025
Synopsis
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
The global Non-Oncology Precision Medicine market was valued at US$ 83330 million in 2023 and is anticipated to reach US$ 111430 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Non-Oncology Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Oncology Precision Medicine.
Report Scope
The Non-Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Oncology Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Oncology Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc.
Asuragen, Inc.
Almac Group
AstraZeneca PLC
Bristol Myers Squibb
bioMérieux SA.
BGI
Danaher Corp.
Illumina, Inc.
Invitae Corporation
Opko Health, Inc.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Segment by Application
Infectious Diseases
Neurology
Cardiovascular
Lifestyle and Endocrinology
Gastroenterology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Oncology Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
The global Non-Oncology Precision Medicine market was valued at US$ 83330 million in 2023 and is anticipated to reach US$ 111430 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Non-Oncology Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Oncology Precision Medicine.
Report Scope
The Non-Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Oncology Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Oncology Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc.
Asuragen, Inc.
Almac Group
AstraZeneca PLC
Bristol Myers Squibb
bioMérieux SA.
BGI
Danaher Corp.
Illumina, Inc.
Invitae Corporation
Opko Health, Inc.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Segment by Application
Infectious Diseases
Neurology
Cardiovascular
Lifestyle and Endocrinology
Gastroenterology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Oncology Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Non-Oncology Precision Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Diseases
1.3.3 Neurology
1.3.4 Cardiovascular
1.3.5 Lifestyle and Endocrinology
1.3.6 Gastroenterology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Oncology Precision Medicine Market Perspective (2019-2030)
2.2 Non-Oncology Precision Medicine Growth Trends by Region
2.2.1 Global Non-Oncology Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Oncology Precision Medicine Historic Market Size by Region (2019-2024)
2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Region (2025-2030)
2.3 Non-Oncology Precision Medicine Market Dynamics
2.3.1 Non-Oncology Precision Medicine Industry Trends
2.3.2 Non-Oncology Precision Medicine Market Drivers
2.3.3 Non-Oncology Precision Medicine Market Challenges
2.3.4 Non-Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Non-Oncology Precision Medicine Players by Revenue (2019-2024)
3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue
3.4 Global Non-Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Oncology Precision Medicine Revenue in 2023
3.5 Non-Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Non-Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Non-Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Oncology Precision Medicine Breakdown Data by Type
4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2019-2024)
4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2025-2030)
5 Non-Oncology Precision Medicine Breakdown Data by Application
5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2019-2024)
5.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-Oncology Precision Medicine Market Size (2019-2030)
6.2 North America Non-Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Oncology Precision Medicine Market Size by Country (2019-2024)
6.4 North America Non-Oncology Precision Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Oncology Precision Medicine Market Size (2019-2030)
7.2 Europe Non-Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024)
7.4 Europe Non-Oncology Precision Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2019-2030)
8.2 Asia-Pacific Non-Oncology Precision Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Oncology Precision Medicine Market Size (2019-2030)
9.2 Latin America Non-Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Oncology Precision Medicine Market Size by Country (2019-2024)
9.4 Latin America Non-Oncology Precision Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2019-2030)
10.2 Middle East & Africa Non-Oncology Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Detail
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Detail
11.3.2 Asuragen, Inc. Business Overview
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction
11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.3.5 Asuragen, Inc. Recent Development
11.4 Almac Group
11.4.1 Almac Group Company Detail
11.4.2 Almac Group Business Overview
11.4.3 Almac Group Non-Oncology Precision Medicine Introduction
11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.4.5 Almac Group Recent Development
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Detail
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction
11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.5.5 AstraZeneca PLC Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction
11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 bioMérieux SA.
11.7.1 bioMérieux SA. Company Detail
11.7.2 bioMérieux SA. Business Overview
11.7.3 bioMérieux SA. Non-Oncology Precision Medicine Introduction
11.7.4 bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.7.5 bioMérieux SA. Recent Development
11.8 BGI
11.8.1 BGI Company Detail
11.8.2 BGI Business Overview
11.8.3 BGI Non-Oncology Precision Medicine Introduction
11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.8.5 BGI Recent Development
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Detail
11.9.2 Danaher Corp. Business Overview
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction
11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.9.5 Danaher Corp. Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Detail
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction
11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.10.5 Illumina, Inc. Recent Development
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Detail
11.11.2 Invitae Corporation Business Overview
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction
11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.11.5 Invitae Corporation Recent Development
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Detail
11.12.2 Opko Health, Inc. Business Overview
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction
11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.12.5 Opko Health, Inc. Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2019-2024)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Non-Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Applied Sciences
Table 3. Key Players of Precision Diagnostics
Table 4. Key Players of Digital Health and Information Technology
Table 5. Key Players of Precision Therapeutics
Table 6. Global Non-Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Non-Oncology Precision Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Non-Oncology Precision Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Non-Oncology Precision Medicine Market Share by Region (2019-2024)
Table 10. Global Non-Oncology Precision Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Non-Oncology Precision Medicine Market Share by Region (2025-2030)
Table 12. Non-Oncology Precision Medicine Market Trends
Table 13. Non-Oncology Precision Medicine Market Drivers
Table 14. Non-Oncology Precision Medicine Market Challenges
Table 15. Non-Oncology Precision Medicine Market Restraints
Table 16. Global Non-Oncology Precision Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Non-Oncology Precision Medicine Market Share by Players (2019-2024)
Table 18. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2023)
Table 19. Ranking of Global Top Non-Oncology Precision Medicine Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Non-Oncology Precision Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Oncology Precision Medicine Product Solution and Service
Table 23. Date of Enter into Non-Oncology Precision Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Oncology Precision Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2019-2024)
Table 27. Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2025-2030)
Table 29. Global Non-Oncology Precision Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2019-2024)
Table 31. Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2025-2030)
Table 33. North America Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Non-Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Non-Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Non-Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Non-Oncology Precision Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Non-Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Non-Oncology Precision Medicine Product
Table 51. Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent Technologies, Inc. Company Detail
Table 54. Agilent Technologies, Inc. Business Overview
Table 55. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product
Table 56. Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 57. Agilent Technologies, Inc. Recent Development
Table 58. Asuragen, Inc. Company Detail
Table 59. Asuragen, Inc. Business Overview
Table 60. Asuragen, Inc. Non-Oncology Precision Medicine Product
Table 61. Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 62. Asuragen, Inc. Recent Development
Table 63. Almac Group Company Detail
Table 64. Almac Group Business Overview
Table 65. Almac Group Non-Oncology Precision Medicine Product
Table 66. Almac Group Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 67. Almac Group Recent Development
Table 68. AstraZeneca PLC Company Detail
Table 69. AstraZeneca PLC Business Overview
Table 70. AstraZeneca PLC Non-Oncology Precision Medicine Product
Table 71. AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 72. AstraZeneca PLC Recent Development
Table 73. Bristol Myers Squibb Company Detail
Table 74. Bristol Myers Squibb Business Overview
Table 75. Bristol Myers Squibb Non-Oncology Precision Medicine Product
Table 76. Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 77. Bristol Myers Squibb Recent Development
Table 78. bioMérieux SA. Company Detail
Table 79. bioMérieux SA. Business Overview
Table 80. bioMérieux SA. Non-Oncology Precision Medicine Product
Table 81. bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 82. bioMérieux SA. Recent Development
Table 83. BGI Company Detail
Table 84. BGI Business Overview
Table 85. BGI Non-Oncology Precision Medicine Product
Table 86. BGI Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 87. BGI Recent Development
Table 88. Danaher Corp. Company Detail
Table 89. Danaher Corp. Business Overview
Table 90. Danaher Corp. Non-Oncology Precision Medicine Product
Table 91. Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 92. Danaher Corp. Recent Development
Table 93. Illumina, Inc. Company Detail
Table 94. Illumina, Inc. Business Overview
Table 95. Illumina, Inc. Non-Oncology Precision Medicine Product
Table 96. Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 97. Illumina, Inc. Recent Development
Table 98. Invitae Corporation Company Detail
Table 99. Invitae Corporation Business Overview
Table 100. Invitae Corporation Non-Oncology Precision Medicine Product
Table 101. Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 102. Invitae Corporation Recent Development
Table 103. Opko Health, Inc. Company Detail
Table 104. Opko Health, Inc. Business Overview
Table 105. Opko Health, Inc. Non-Oncology Precision Medicine Product
Table 106. Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 107. Opko Health, Inc. Recent Development
Table 108. Teva Pharmaceutical Industries Ltd. Company Detail
Table 109. Teva Pharmaceutical Industries Ltd. Business Overview
Table 110. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product
Table 111. Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2019-2024) & (US$ Million)
Table 112. Teva Pharmaceutical Industries Ltd. Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Oncology Precision Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-Oncology Precision Medicine Market Share by Type: 2023 VS 2030
Figure 3. Applied Sciences Features
Figure 4. Precision Diagnostics Features
Figure 5. Digital Health and Information Technology Features
Figure 6. Precision Therapeutics Features
Figure 7. Global Non-Oncology Precision Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Non-Oncology Precision Medicine Market Share by Application: 2023 VS 2030
Figure 9. Infectious Diseases Case Studies
Figure 10. Neurology Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Lifestyle and Endocrinology Case Studies
Figure 13. Gastroenterology Case Studies
Figure 14. Others Case Studies
Figure 15. Non-Oncology Precision Medicine Report Years Considered
Figure 16. Global Non-Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Non-Oncology Precision Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Non-Oncology Precision Medicine Market Share by Region: 2023 VS 2030
Figure 19. Global Non-Oncology Precision Medicine Market Share by Players in 2023
Figure 20. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2023
Figure 22. North America Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Non-Oncology Precision Medicine Market Share by Country (2019-2030)
Figure 24. United States Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Non-Oncology Precision Medicine Market Share by Country (2019-2030)
Figure 28. Germany Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Non-Oncology Precision Medicine Market Share by Region (2019-2030)
Figure 36. China Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Non-Oncology Precision Medicine Market Share by Country (2019-2030)
Figure 44. Mexico Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Non-Oncology Precision Medicine Market Share by Country (2019-2030)
Figure 48. Turkey Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Non-Oncology Precision Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Abbott Laboratories Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 52. Asuragen, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 53. Almac Group Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 54. AstraZeneca PLC Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 56. bioMérieux SA. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 57. BGI Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 58. Danaher Corp. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 59. Illumina, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 60. Invitae Corporation Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 61. Opko Health, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
